Skip to Main Content

Paper Details

Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia.
Am Soc Clin Oncol Educ Book
10
2023
Author NameAffiliation
Jessica LeonardKnight Cancer Institute, Oregon Health & Science University
Michael HeuserHannover Medical School
Michael HeuserComprehensive Cancer Center Lower Saxony
  • 1 - 3

Datasets

Release 1.2